VSee Health, Inc. Stock-Based Compensation
VSee Health, Inc. (VSEE) reported Stock-Based Compensation of $643.86 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- VSee Health, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $202.56K, a 45.54% decline year-over-year.
- VSee Health, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $441.31K, a 12.55% increase year-over-year.
- VSee Health, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $360.48K, a 8.30% decline year-over-year.
- VSee Health, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- VSee Health, Inc. share-based payment arrangement, expense for fiscal 2025 was $1.12M, a 25.43% increase from fiscal 2024.
- VSee Health, Inc. share-based payment arrangement, expense for fiscal 2024 was $896.54K.
- VSee Health, Inc. share-based payment arrangement, expense for fiscal 2023 was $0.00.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $202.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $643.86K 10-Q · filed 2026-08-14 | $1.00M derived: sum of 3 quarters · filed 2026-08-14 | $1.00M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $441.31K 10-Q · filed 2026-05-15 | $801.79K derived: sum of 2 quarters · filed 2026-05-15 | $801.79K derived: sum of 3 quarters · filed 2026-05-15 | $1.17M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $360.48K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $360.48K derived: sum of 2 quarters · filed 2026-03-31 | $732.41K derived: sum of 3 quarters · filed 2026-08-14 | $1.12M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $371.93K derived: sum of 2 quarters · filed 2026-08-14 | $764.04K 10-Q · filed 2025-11-14 | $1.16M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $371.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $764.04K 10-Q · filed 2026-08-14 | $1.16M derived: sum of 3 quarters · filed 2026-08-14 | $1.51M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $392.11K 10-Q · filed 2026-05-15 | $785.21K derived: sum of 2 quarters · filed 2026-05-15 | $1.13M derived: sum of 3 quarters · filed 2026-05-15 | $1.17M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $393.10K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $742.20K derived: sum of 2 quarters · filed 2026-03-31 | $774.19K derived: sum of 3 quarters · filed 2026-03-31 | $896.54K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $349.10K 10-Q · filed 2024-11-14 | $381.08K derived: sum of 2 quarters · filed 2024-11-14 | $503.43K 10-Q · filed 2025-11-14 | $381.08K 10-Q · filed 2024-11-14 | $381.08K derived: sum of 4 quarters · filed 2025-10-15 | |
| 2024-06-30 | $31.99K 10-Q · filed 2024-09-23 | $474.25K 10-Q/A · filed 2025-11-20 | $31.99K 10-Q · filed 2024-09-23 | $31.99K derived: sum of 3 quarters · filed 2025-10-15 | $31.99K derived: sum of 4 quarters · filed 2025-10-15 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-10-15 | $0.00 derived: sum of 2 quarters · filed 2025-10-15 | $0.00 derived: sum of 3 quarters · filed 2025-10-15 | $0.00 derived: sum of 4 quarters · filed 2025-10-15 | ||
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | $0.00 derived: sum of 2 quarters · filed 2025-08-29 | $0.00 derived: sum of 3 quarters · filed 2025-08-29 | $0.00 10-K/A · filed 2025-08-29 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $0.00 10-Q · filed 2024-09-23 | $0.00 10-Q · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |